share_log

Astria Therapeutics: Final 3- and 6-Mo Results From ALPHA-STAR Trial of Navenibart Expected in 4Q

Astria Therapeutics: Final 3- and 6-Mo Results From ALPHA-STAR Trial of Navenibart Expected in 4Q

Astria Therapeutics:Navenibart的ALPHA-STAR试验的最终3个月和6个月结果预计在第四季度公布
道琼斯 ·  2024/11/14 05:20

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发